go back and read Mike Fuller's article at Seeking Alpha
If LONG's have not yet done so, you may want to go look at Mike Fuller's articles at Seeking Alpha, regarding QCOR. These are all well written, very in depth analysis, with lots of medical details and facts for Acthar.
I've read them and re-read them looking for errors or misinterpretations and I cant find any. Impressive.
Which is why I am LONG Qcor
Mike's articles may even be more timely now than ever as we are just around the corner from Qcor's April conf. call and earnings release.
Fasten your seat belts....